Long-Term Sirolimus for Primary Immunosuppression and Incidence of De Novo Malignancy Following Heart Transplantation

被引：0
|
作者：
Asleh, R. [1 ]
Li, X. [1 ]
Alnsasra, H. [2 ]
Briasoulis, A. [1 ]
Smith, B. [1 ]
Kremers, W. [1 ]
Pereira, N. L. [1 ]
Edwards, B. S. [1 ]
Daly, R. C. [1 ]
Stulak, J. M. [1 ]
Clavell, A. [1 ]
Kushwaha, S. S. [1 ]
机构：
[1] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA
[2] Mayo Clin, Cardiovasc Dis, Rochester, MN USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2019年 / 38卷 / 04期
关键词：
D O I：
10.1016/j.healun.2019.01.682
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
672
引用
收藏
页码：S274 / S274
页数：1
相关论文
共 50 条
  • [1] Long-Term Sirolimus for Primary Immunosuppression is Associated With Decreased Incidence of Malignancies After Heart Transplantation
    Asleh, Rabea
    Pereira, Naveen L.
    Kremers, Walter
    Smith, Byron
    Li, Xin
    Edwards, Brooks S.
    Daly, Richard C.
    Kushwaha, Sudhir S.
    [J]. CIRCULATION, 2018, 138
  • [2] Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant Recipients
    Asleh, Rabea
    Briasoulis, Alexandros
    Kremers, Walter K.
    Adigun, Rosalyn
    Boilson, Barry A.
    Pereira, Naveen L.
    Edwards, Brooks S.
    Clavell, Alfredo L.
    Schirger, John A.
    Rodeheffer, Richard J.
    Frantz, Robert P.
    Joyce, Lyle D.
    Maltais, Simon
    Stulak, John M.
    Daly, Richard C.
    Tilford, Jonella
    Choi, Woong-Gil
    Lerman, Amir
    Kushwaha, Sudhir S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (06) : 636 - 650
  • [3] The Dose Matters: Long-Term Immunosuppression's Influence On De Novo Malignancy After Liver Transplantation.
    Kaltenborn, A.
    Kleine, M.
    Vogel, A.
    Klempnauer, J.
    Schrem, H.
    [J]. TRANSPLANTATION, 2014, 98 : 161 - 161
  • [4] The Dose Matters: Long-Term Immunosuppression's Influence On De Novo Malignancy After Liver Transplantation.
    Kaltenborn, A.
    Kleine, M.
    Vogel, A.
    Klempnauer, J.
    Schrem, H.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 161 - 161
  • [5] De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: Long-term outcomes and side effects
    Toso, Christian
    Meeberg, Glenda A.
    Bigam, David L.
    Oberholzer, Jose
    Shapiro, A. M. James
    Gutfreund, Klaus
    Ma, Mang M.
    Mason, Andrew L.
    Wong, Winnie W. S.
    Bain, Vincent G.
    Kneteman, Norman M.
    [J]. TRANSPLANTATION, 2007, 83 (09) : 1162 - 1168
  • [6] LONG-TERM OUTCOMES OF DE NOVO MALIGNANCY AFTER LIVER TRANSPLANTATION FOR ALCOHOLIC CIRRHOSIS
    Pascale, Marco Maria
    Nure, Erida
    Bianco, Giuseppe
    Frongillo, Francesco
    Agnes, Salvatore
    [J]. TRANSPLANT INTERNATIONAL, 2021, 34 : 333 - 334
  • [7] Long-term Probability of and Mortality From De Novo Malignancy After Liver Transplantation
    Watt, Kymberly D. S.
    Pedersen, Rachel A.
    Kremers, Walter K.
    Heimbach, Julie K.
    Sanchez, William
    Gores, Gregory J.
    [J]. GASTROENTEROLOGY, 2009, 137 (06) : 2010 - 2017
  • [8] Long-term immunosuppression and malignancy in thoracic transplantation: Where is the balance?
    Nair, Nandini
    Gongora, Enrique
    Mehra, Mandeep R.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (05): : 461 - 467
  • [9] Incidence, Risk Factors, and Outcomes of De Novo Malignancy following Kidney Transplantation
    Chukwu, Chukwuma A.
    Wu, Henry H. L.
    Pullerits, Kairi
    Garland, Shona
    Middleton, Rachel
    Chinnadurai, Rajkumar
    Kalra, Philip A.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)
  • [10] Temporal Trends of Incidence and Types of De Novo Malignancy after Heart Transplantation
    Youn, J.
    Edwards, L. B.
    Lund, L. H.
    Stehlik, J.
    Kang, S.
    Kobashigawa, J. A.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S64 - S65
12345